Epigenetic aging in older breast cancer survivors and non‐cancer controls: preliminary findings from the Thinking and Living with Cancer (TLC) Study

Study examined whether older breast cancer survivors showed greater epigenetic aging than noncancer controls . Older survivors were 1.04 to 2.22 years biologically older than controls on Horvath, EEA, GrimAge, Dunedin Pace of Aging measures . An older age related to worse physical function in all women, including those exposed to chemotherapy . If replicated,… Continue reading Epigenetic aging in older breast cancer survivors and non‐cancer controls: preliminary findings from the Thinking and Living with Cancer (TLC) Study